The DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.
A review of nanocarriers for the delivery of small interfering RNA
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00248-5 · Cited by 6,565
Role for a bidentate ribonuclease in the initiation step of RNA interference
Bernstein, E., Caudy, A. A., Hammond, S. M., & Hannon, G. J. (2001) · Nature · doi:10.1038/35053110 · Cited by 4,892
Drug Delivery Systems: Entering the Mainstream
Allen, T. M., & Cullis, P. R. (2004) · Science · doi:10.1126/science.1095833 · Cited by 4,552
Tomalia, D. A., Naylor, A. M., & Goddard, W. A. (1990) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199001381 · Cited by 3,211
Nanoparticle and targeted systems for cancer therapy
Brannon-Peppas, L., & Blanchette, J. O. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.02.014 · Cited by 2,334
Cancer burden in the year 2000. The global picture
Parkin, D. M., Bray, F. I., & Devesa, S. S. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00267-2 · Cited by 2,169
Optimizing Liposomes for Delivery of Chemotherapeutic Agents to Solid Tumors
Drummond, D. C., Meyer, O., Hong, K., Kirpotin, D. B., & Papahadjopoulos, D. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01426-1 · Cited by 1,263
Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA
Judge, A. D., Sood, V., Shaw, J. R., Fang, D., McClintock, K., & MacLachlan, I. (2005) · Nature Biotechnology · doi:10.1038/nbt1081 · Cited by 1,250
Mechanics of receptor-mediated endocytosis
Gao, H., Shi, W., & Freund, L. B. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503879102 · Cited by 1,217
Polyamidoamine cascade polymers mediate efficient transfection of cells in culture
Haensler, J., & Szoka, F. C. (1993) · Bioconjugate Chemistry · doi:10.1021/bc00023a012 · Cited by 1,207
Interfering with disease: a progress report on siRNA-based therapeutics
de Fougerolles, A., Vornlocher, H.-P., Maraganore, J., & Lieberman, J. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2310 · Cited by 1,203
Functionalized Carbon Nanotubes for Plasmid DNA Gene Delivery
Pantarotto, D., Singh, R., McCarthy, D., Erhardt, M., Briand, J., Prato, M., Kostarelos, K., & Bianco, A. (2004) · Angewandte Chemie International Edition · doi:10.1002/anie.200460437 · Cited by 1,091
Biomedical applications of functionalised carbon nanotubes
Bianco, A., Kostarelos, K., Partidos, C. D., & Prato, M. (2005) · Chemical Communications · doi:10.1039/b410943k · Cited by 1,086
RNAi therapeutics: a potential new class of pharmaceutical drugs
Bumcrot, D., Manoharan, M., Koteliansky, V., & Sah, D. W. Y. (2006) · Nature Chemical Biology · doi:10.1038/nchembio839 · Cited by 1,085
Single Processing Center Models for Human Dicer and Bacterial RNase III
Zhang, H., Kolb, F. A., Jaskiewicz, L., Westhof, E., & Filipowicz, W. (2004) · Cell · doi:10.1016/j.cell.2004.06.017 · Cited by 1,041
Carbon nanotubes as nanomedicines: From toxicology to pharmacology☆
LACERDA, L., BIANCO, A., PRATO, M., & KOSTARELOS, K. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.09.015 · Cited by 839
Dendrimers: From Design to Application—A Progress Report
Fischer, M., & Vögtle, F. (1999) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(19990401)38:7<884::aid-anie884>3.0.co;2-k · Cited by 828
Position-specific chemical modification of siRNAs reduces “off-target” transcript silencing
Jackson, A. L., Burchard, J., Leake, D., Reynolds, A., Schelter, J., Guo, J., Johnson, J. M., Lim, L., Karpilow, J., Nichols, K., et al. (2006) · RNA · doi:10.1261/rna.30706 · Cited by 789
Therapeutic EphA2 Gene Targeting In vivo Using Neutral Liposomal Small Interfering RNA Delivery
Landen, C. N., Chavez-Reyes, A., Bucana, C., Schmandt, R., Deavers, M. T., Lopez-Berestein, G., & Sood, A. K. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0530 · Cited by 675
siRNA Delivery into Human T Cells and Primary Cells with Carbon‐Nanotube Transporters
Liu, Z., Winters, M., Holodniy, M., & Dai, H. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200604295 · Cited by 666
Wang, Y., Gao, S., Ye, W.-H., Yoon, H. S., & Yang, Y.-Y. (2006) · Nature Materials · doi:10.1038/nmat1737 · Cited by 658
siRNA delivery systems for cancer treatment
Oh, Y.-K., & Park, T. G. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.04.018 · Cited by 645
Lipid-based Nanoparticles for Nucleic Acid Delivery
Li, W., & Szoka, F. C. (2007) · Pharmaceutical Research · doi:10.1007/s11095-006-9180-5 · Cited by 641
Inorganic Nanoparticles as Carriers of Nucleic Acids into Cells
Sokolova, V., & Epple, M. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200703039 · Cited by 581
Highly efficient molecular delivery into mammalian cells using carbon nanotube spearing
Cai, D., Mataraza, J. M., Qin, Z.-H., Huang, Z., Huang, J., Chiles, T. C., Carnahan, D., Kempa, K., & Ren, Z. (2005) · Nature Methods · doi:10.1038/nmeth761 · Cited by 552
A PEGylated dendritic nanoparticulate carrier of fluorouracil
Bhadra, D., Bhadra, S., Jain, S., & Jain, N. K. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00132-7 · Cited by 544
Self-citationFunctionalized carbon nanotubes as emerging nanovectors for the delivery of therapeutics
Klumpp, C., Kostarelos, K., Prato, M., & Bianco, A. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2005.10.008 · Cited by 540
Systemic Leukocyte-Directed siRNA Delivery Revealing Cyclin D1 as an Anti-Inflammatory Target
Peer, D., Park, E. J., Morishita, Y., Carman, C. V., & Shimaoka, M. (2008) · Science · doi:10.1126/science.1149859 · Cited by 493
Water-soluble dendritic unimolecular micelles:
Liu, M., Kono, K., & Fréchet, J. M. J. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00245-x · Cited by 477
Biodegradable calcium phosphate nanoparticle with lipid coating for systemic siRNA delivery
Li, J., Chen, Y.-C., Tseng, Y.-C., Mozumdar, S., & Huang, L. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.11.008 · Cited by 470
Nonviral delivery of synthetic siRNAs in vivo
Akhtar, S., & Benter, I. F. (2007) · Journal of Clinical Investigation · doi:10.1172/jci33494 · Cited by 464
Gene Silencing by Systemic Delivery of Synthetic siRNAs in Adult Mice
Sørensen, D. R., Leirdal, M., & Sioud, M. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(03)00181-5 · Cited by 464
Carbon Nanotubes for Biomedical Applications
Sinha, N., & Yeow, J. T.-W. (2005) · IEEE Transactions on Nanobioscience · doi:10.1109/tnb.2005.850478 · Cited by 450
A novel siRNA-lipoplex technology for RNA interference in the mouse vascular endothelium
Santel, A., Aleku, M., Keil, O., Endruschat, J., Esche, V, Fisch, G., Dames, S., Löffler, K., Fechtner, M., Arnold, W., et al. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302777 · Cited by 368
Taratula, O., Garbuzenko, O. B., Kirkpatrick, P., Pandya, I., Savla, R., Pozharov, V. P., He, H., & Minko, T. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.06.019 · Cited by 328
Zhang, Z., Yang, X., Zhang, Y., Zeng, B., Wang, S., Zhu, T., Roden, R. B. S., Chen, Y., & Yang, R. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2831 · Cited by 317
Engineering RNA for Targeted siRNA Delivery and Medical Application
Guo, P., Coban, O., Snead, N. M., Trebley, J., Hoeprich, S., Guo, S., & Shu, Y. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.03.008 · Cited by 300
Halder, J., Kamat, A. A., Landen, C. N., Han, L. Y., Lutgendorf, S. K., Lin, Y. G., Merritt, W. M., Jennings, N. B., Chavez-Reyes, A., Coleman, R. L., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0021 · Cited by 297
Quantum-dot based nanoparticles for targeted silencing of HER2/neu gene via RNA interference
Tan, W. B., Jiang, S., & Zhang, Y. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2006.11.018 · Cited by 295
Li, S.-D., & Huang, L. (2006) · Molecular Pharmaceutics · doi:10.1021/mp060039w · Cited by 282
PEG conjugated VEGF siRNA for anti-angiogenic gene therapy
Kim, S. H., Jeong, J. H., Lee, S. H., Kim, S. W., & Park, T. G. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.05.023 · Cited by 273
Gillies, E. R., Dy, E., Fréchet, J. M. J., & Szoka, F. C. (2005) · Molecular Pharmaceutics · doi:10.1021/mp049886u · Cited by 265
Merritt, W. M., Lin, Y. G., Spannuth, W. A., Fletcher, M. S., Kamat, A. A., Han, L. Y., Landen, C. N., Jennings, N., De Geest, K., Langley, R. R., et al. (2008) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djn024 · Cited by 257
Hatakeyama, H., Ito, E., Akita, H., Oishi, M., Nagasaki, Y., Futaki, S., & Harashima, H. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.06.008 · Cited by 254
Drug delivery of siRNA therapeutics: potentials and limits of nanosystems
Reischl, D., & Zimmer, A. (2009) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2008.06.001 · Cited by 253
pDNA loaded calcium phosphate nanoparticles: highly efficient non-viral vector for gene delivery
Bisht, S., Bhakta, G., Mitra, S., & Maitra, A. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.07.035 · Cited by 253
The Epidemiology of Cervical Cancer
Franco, E. L., Schlecht, N. F., & Saslow, D. (2003) · The Cancer Journal · doi:10.1097/00130404-200309000-00004 · Cited by 246
Podesta, J. E., Al‐Jamal, K. T., Herrero, M. A., Tian, B., Ali‐Boucetta, H., Hegde, V., Bianco, A., Prato, M., & Kostarelos, K. (2009) · Small · doi:10.1002/smll.200801572 · Cited by 241
Chono, S., Li, S.-D., Conwell, C. C., & Huang, L. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.07.006 · Cited by 238
Khaled, A., Guo, S., Li, F., & Guo, P. (2005) · Nano Letters · doi:10.1021/nl051264s · Cited by 233
Hydrophobization and bioconjugation for enhanced siRNA delivery and targeting
De Paula, D., Bentley, M. V. L. B., & Mahato, R. I. (2007) · RNA · doi:10.1261/rna.459807 · Cited by 228
The synthesis of water soluble dendrimers, and their application as possible drug delivery systems
Twyman, L. J., Beezer, A. E., Esfand, R., Hardy, M. J., & Mitchell, J. C. (1999) · Tetrahedron Letters · doi:10.1016/s0040-4039(98)02680-x · Cited by 219
Patil, M. L., Zhang, M., Taratula, O., Garbuzenko, O. B., He, H., & Minko, T. (2009) · Biomacromolecules · doi:10.1021/bm8009973 · Cited by 213
Surface-Modified and Internally Cationic Polyamidoamine Dendrimers for Efficient siRNA Delivery
Patil, M. L., Zhang, M., Betigeri, S., Taratula, O., He, H., & Minko, T. (2008) · Bioconjugate Chemistry · doi:10.1021/bc8000722 · Cited by 213
Patil, M. L., Zhang, M., & Minko, T. (2011) · ACS Nano · doi:10.1021/nn102711d · Cited by 210
The role of nanobiotechnology in drug discovery
Jain, K. K. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03573-7 · Cited by 207
Tanaka, T., Shiramoto, S., Miyashita, M., Fujishima, Y., & Kaneo, Y. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.09.050 · Cited by 206
Dutta, T., & Jain, N. K. (2007) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2006.12.007 · Cited by 200
Self-citationP-glycoprotein, multidrug resistance and tumor progression
Bradley, G., & Ling, V. (1994) · Cancer and Metastasis Reviews · doi:10.1007/bf00689638 · Cited by 195
Cancer targeting potential of some ligand-anchored poly(propylene imine) dendrimers: a comparison
Kesharwani, P., Tekade, R. K., Gajbhiye, V., Jain, K., & Jain, N. K. (2011) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2010.10.010 · Cited by 184
Self-citationPegnology: a review of PEG-ylated systems.
Bhadra, D., Bhadra, S., Jain, P., & Jain, N. K. (2002) · PubMed · Cited by 183
Self-citationWeber, N., Ortega, P., Clemente, M. I., Shcharbin, D., Bryszewska, M., de la Mata, F. J., Gómez, R., & Muñoz-Fernández, M. A. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.07.035 · Cited by 175
Pillé, J.-Y., Li, H., Blot, E., Bertrand, J.-R., Pritchard, L.-L., Opolon, P., Maksimenko, A., Lu, H., Vannier, J.-P., Soria, J., et al. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.1019 · Cited by 167
Therapeutic Targeting of Neuropilin-2 on Colorectal Carcinoma Cells Implanted in the Murine Liver
Gray, M. J., Van Buren, G., Dallas, N. A., Xia, L., Wang, X., Yang, A. D., Somcio, R. J., Lin, Y. G., Lim, S., Fan, F., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm279 · Cited by 158
Huh, M. S., Lee, S. Y., Park, S.-J., Lee, S., Chung, H., Lee, S., Choi, Y., Oh, Y., Park, J. H., Jeong, S. Y., et al. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.02.023 · Cited by 157
Efficient gene silencing in metastatic tumor by siRNA formulated in surface-modified nanoparticles
Li, S., Chono, S., & Huang, L. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.11.002 · Cited by 151
Oupický, D., Carlisle, R. C., & Seymour, L. W. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301446 · Cited by 151
Ito, T., Iida‐Tanaka, N., Niidome, T., Kawano, T., Kubo, K., Yoshikawa, K., Sato, T., Yang, Z., & Koyama, Y. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.03.013 · Cited by 150
Jiang, J., Yang, S.-J., Wang, J., Yang, L., Xu, Z.-Z., Yang, T., Liu, X.-Y., & Zhang, Q. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.06.011 · Cited by 149
Functional Delivery of siRNA in Mice Using Dendriworms
Agrawal, A., Min, D., Singh, N., Zhu, H., Birjiniuk, A., von Maltzahn, G., Harris, T. J., Xing, D., Woolfenden, S. D., Sharp, P. A., et al. (2009) · ACS Nano · doi:10.1021/nn900201e · Cited by 147
SiRNA delivery with functionalized carbon nanotubes
Varkouhi, A. K., Foillard, S., Lammers, T., Schiffelers, R. M., Doris, E., Hennink, W. E., & Storm, G. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.02.009 · Cited by 141
Pillé, J.-Y., Li, H., Blot, E., Bertrand, J., Pritchard, L. L., Opolon, P., Maksimenko, A., Lu, H., Vannier, J., Soria, J., et al. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.ft-248 · Cited by 140
Kim, H. R., Kim, I. K., Bae, K. H., Hyeon, L. S., Lee, Y., & Park, T. G. (2008) · Molecular Pharmaceutics · doi:10.1021/mp8000233 · Cited by 139
Applications of RNA interference: current state and prospects for siRNA-based strategies in vivo
Aigner, A. M. (2007) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-007-0984-y · Cited by 135
Chisti, Y. (1999) · Biotechnology Advances · doi:10.1016/s0734-9750(99)00009-9 · Cited by 134
Krajcik, R., Jung, A., Hirsch, A., Neuhuber, W., & Zolk, O. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.02.072 · Cited by 134
Iyer, A. K., Greish, K. F., Seki, T., Okazaki, S., Fang, J. Q., Takeshita, K., & Maeda, H. (2007) · Journal of drug targeting · doi:10.1080/10611860701498252 · Cited by 126
Targeted Delivery of Small Interfering RNA: Approaching Effective Cancer Therapies
Pirollo, K. F., & Chang, E. H. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5810 · Cited by 121
Gao, J., Liu, W., Xia, Y., Li, W., Sun, J. F., Chen, H., Li, B., Zhang, D., Qian, W., Meng, Y., et al. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.01.034 · Cited by 119
Efficient delivery of siRNA using dendritic poly(l-lysine) for loss-of-function analysis
Inoue, Y., Kurihara, R., Tsuchida, A., Hasegawa, M., Nagashima, T., Mori, T., Niidome, T., Katayama, Y., & Okitsu, O. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.10.022 · Cited by 119
Intravascular and Endobronchial DNA Delivery to Murine Lung Tissue Using a Novel, Nonviral Vector
Kukowska‐Latallo, J. F., Chen, C., Raczka, E., Qunintana, A., Rymaszewski, M., & Baker, J. R. (2000) · Human Gene Therapy · doi:10.1089/10430340050057468 · Cited by 116
Janoff, A. S. (1999) · M. Dekker eBooks · Cited by 104
Delivery of siRNA into breast cancer cells via phage fusion protein-targeted liposomes
Bedi, D., Musacchio, T., Fagbohun, O. A., Gillespie, J. W., DeInnocentes, P., Bird, R. C., Bookbinder, L., Torchilin, V. P., & Petrenko, V. A. (2010) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2010.10.004 · Cited by 104
Shim, G., Han, S.-E., Yu, Y.-H., Lee, S. B., Lee, H. Y., Kim, K., Kwon, I. C., Park, T. G., Kim, Y. B., Choi, Y. S., et al. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.10.017 · Cited by 103
Kenny, G. D., Kamaly, N., Kalber, T. L., Brody, L., Sahuri-Arisoylu, M., Shamsaei, E., Miller, A. D., & Bell, J. D. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.09.020 · Cited by 100
Folate-linked lipid-based nanoparticles for synthetic siRNA delivery in KB tumor xenografts
Yoshizawa, T., Hattori, Y., Hakoshima, M., Koga, K., & Maitani, Y. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.06.026 · Cited by 99
Therapeutic potential of RNA interference for neurological disorders
Sah, D. W. Y. (2006) · Life Sciences · doi:10.1016/j.lfs.2006.06.011 · Cited by 96
Zheng, X., Vladau, C., Zhang, X., Suzuki, M., Ichim, T. E., Zhang, Z., Li, M., Carrier, E., Garcia, B. M., Jevnikar, A. M., et al. (2009) · Blood · doi:10.1182/blood-2008-04-151191 · Cited by 95
Gupta, U. D., Agashe, H. B., & Jain, N. K. (2007) · PubMed · Cited by 93
Self-citationNovel Water‐Soluble Carbosilane Dendrimers: Synthesis and Biocompatibility
Ortega, P., Bermejo-Martín, J. F., Chonco, L., de Jesús, E., de la Mata, F. J., Fernández, G., Flores, J. C., Gómez, R., Serramía, M. J., & Muñoz‐Fernández, M. Á. (2006) · European Journal of Inorganic Chemistry · doi:10.1002/ejic.200500782 · Cited by 67
de Martimprey, H., Bertrand, J., Fusco, A., Santoro, M. M., Couvreur, P., Vauthier, C., & Malvy, C. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn882 · Cited by 65
Posadas, I., López‐Hernández, B., Clemente, M. I., Jiménez, J. L., Ortega, P., de la Mata, F. J., Gómez, R., Muñoz‐Fernández, M. Á., & Ceña, V. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9839-9 · Cited by 64
BARRIERS TO SUCCESSFUL DELIVERY OF SHORT INTERFERING RNA AFTER SYSTEMIC ADMINISTRATION
White, P. J. (2008) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2008.04992.x · Cited by 61
Targeted delivery of SiRNA to CD33-positive tumor cells with liposomal carrier systems
Rothdiener, M., Müller, D., Castro, P. G., Scholz, A., Schwemmlein, M., Fey, G. H., Heidenreich, O. T., & Kontermann, R. E. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.02.020 · Cited by 61
de Martimprey, H., Bertrand, J., Fusco, A., Santoro, M. M., Couvreur, P., Vauthier, C., & Malvy, C. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm1094 · Cited by 61
Dendrosome-based delivery of siRNA against E6 and E7 oncogenes in cervical cancer
Dutta, T., Burgess, M. L., McMillan, N. A. J., & Parekh, H. S. (2010) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2009.12.001 · Cited by 54
Liu, H., Guo, S., Roll, R. L., Li, J., Diao, Z., Shao, N., Riley, M. R., Cole, A. M., Robinson, J. P., Snead, N. M., et al. (2007) · Cancer Biology & Therapy · doi:10.4161/cbt.6.5.3962 · Cited by 48
Targeted delivery of anti-coxsackievirus siRNAs using ligand-conjugated packaging RNAs
Zhang, H. M., Su, Y., Guo, S., Ji, Y., Lim, T. W., Liu, J., Guo, P., & Yang, D. (2009) · Antiviral Research · doi:10.1016/j.antiviral.2009.07.005 · Cited by 43
Advances in the development of therapeutic nucleic acids against cervical cancer
DiPaolo, J. A., & Álvarez-Salas, L. M. (2004) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.4.8.1251 · Cited by 38
Chen, A. M., Santhakumaran, L. M., Nair, S. K., Amenta, P. S., Thomas, T., He, H., & Thomas, T. (2006) · Nanotechnology · doi:10.1088/0957-4484/17/21/027 · Cited by 29
Specific subcellular localization of siRNAs delivered by lipoplex in MCF-7 breast cancer cells
Lavigne, C., & Thierry, A. R. (2007) · Biochimie · doi:10.1016/j.biochi.2007.05.002 · Cited by 28
Starlike branched and hyperbranched biodegradable polymer systems as DNA carriers
Vlasov, G. P. (2006) · Russian Journal of Bioorganic Chemistry · doi:10.1134/s1068162006030010 · Cited by 18
Cited by
Delivery materials for siRNA therapeutics
Kanasty, R., Dorkin, J. R., Vegas, A., & Anderson, D. (2013) · Nature Materials · doi:10.1038/nmat3765 · Cited by 1,800
Engineering exosomes as refined biological nanoplatforms for drug delivery
Luan, X., Sansanaphongpricha, K., Myers, I., Chen, H., Yuan, H., & Sun, D. (2017) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.12 · Cited by 1,163
Neural tissue engineering options for peripheral nerve regeneration
Gu, X., Ding, F., & Williams, D. F. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.04.064 · Cited by 630
“Various nanocarrier systems, including liposomes, nanoparticles, dendrimers and carbon nanotubes, have been designed as siRNA delivery vectors to overcome the common biological barriers, especially biodegradation in the bloodstream, renal clearance and inadequate entry into cells [222,223].”
BackgroundDeng, Y., Wang, C. C., Choy, K. W., Du, Q., Chen, J., Wang, Q., Li, L., Chung, T. K. H., & Tang, T. (2014) · Gene · doi:10.1016/j.gene.2013.12.019 · Cited by 301
PAMAM dendrimers as promising nanocarriers for RNAi therapeutics
Kesharwani, P., Banerjee, S., Gupta, U., Mohd Amin, M. C. I., Padhye, S., Sarkar, F. H., & Iyer, A. K. (2015) · Materials Today · doi:10.1016/j.mattod.2015.06.003 · Cited by 290
Self-citation
Metadata
- Authors
- Kesharwani, P., Gajbhiye, V., & Jain, N. K.
- Venue
- Biomaterials
- Publisher
- Elsevier BV
- Published
- 2012-10
- Volume
- 33
- Issue
- 29
- Pages
- 7138-7150
- ISSN
- 0142-9612 (ISSN-L)
- OpenAlex
- W2072715976
- Cited by
- 368
- References
- 102
- FWCI
- 12.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.